Perrigo, the US generic drug company, announced it will invest $40 million over the next three years, in order to expand its R&D and production in its two plants in Israel. As part of the investment, Perrigo says it plans to add 100 employees to its plants in Yeruham and Ramat Hovav in the Israeli Negev. The company currently employs approximately 7,000 employees worldwide, out of them 900 in Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli Inventor Of PDF, MP3, And ZIP Dies
March 30, 2023

Helmet Sends Magnetic Pulses To Treat Depression
March 30, 2023

AI To Monitor Vehicles At Mid-East Borders
March 30, 2023

Wireless Device Monitors Patients’ Vital Signs
March 29, 2023
Facebook comments